Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Investors Lab
  • Published:

Biotechs for pennies?

Nature Biotechnology volume 22, page 1509 (2004)Cite this article

Access through your institution
Buy or subscribe

Have you spied a biotech stock selling for under $5.00 a share or even $1.00 a share? You certainly have a selection: shares of about 150 biotech companies from all over the world sell on US markets today for under a five spot. Conventional wisdom leads us to eschew these companies, called 'penny stocks', as a gambler's nightmare. But this is not always true.

Bulls, bears and penny stocks

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Tom Jacobs
    View author publications

    Search author on:PubMed Google Scholar

Additional information

Tom Jacobs is cofounder of Complete Growth Investor (). He welcomes your comments at . Tom owns no shares of companies mentioned in this article.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jacobs, T. Biotechs for pennies?. Nat Biotechnol 22, 1509 (2004). https://doi.org/10.1038/nbt1204-1509

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt1204-1509

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing